Kodiak Sciences, Inc. (KOD)
25.28
-1.38
(-5.19%)
USD |
NASDAQ |
Feb 20, 16:00
25.30
+0.02
(+0.10%)
After-Hours: 20:00
Kodiak Sciences SG&A Expense (Quarterly) : 11.88M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 117.08M |
| Ionis Pharmaceuticals, Inc. | 96.81M |
| Processa Pharmaceuticals, Inc. | 1.827M |
| Edgewise Therapeutics, Inc. | 9.378M |
| Nuvalent, Inc. | 28.85M |